The medical world is abuzz with excitement over the first drug confirmed to slow the destruction of the brain in Alzheimer's.
The breakthrough medicine called lecanemab, ends decades of failure in finding a treatment.
Almost 70,000 New Zealanders have dementia - with Alzheimer's the most common cause.
Imperial College academic neurologist Paresh Malhotra spoke to Guyon Espiner.
